Not Yet Recruiting
Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line Targeted Therapy
NCT07537777
- Conditions
- Adenocarcinoma, Anlotinib, Benmelstobart, +14 more
- Locations
-
- Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China